Observational studyFarmaceuticos comunitarios2025
[Evaluation of pharmaceutical intervention to patients in the community through telepharmacy].
Observational study in Farmaceuticos comunitarios, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pharmaceutical interventions (PI) are important for the resolution of drug-related problems (DRP). An alternative to efficiently meet this need is telepharmacy, defined as a modality of pharmaceutical services provided remotely through information and communication technologies (ICT). Objectives: To evaluate PI through telepharmacy in terms of their benefit to treatment effectiveness and/or safety. Methods: Retrospective observational study. Data were obtained from the pharmacotherapeutic records of eight community pharmacies that carried out PI through telepharmacy from November 2020 to October 2021. PI were evaluated using impact codes (benefit to treatment effectiveness and/or safety). Results: A total of 21 patients participated, of whom 11 were men. The median age was 61 years (Q1-Q3: 55-67). According to the ATC code, the most prevalent drug groups were: A-Alimentary tract and metabolism (n=38; 24.2%) and C-Cardiovascular system (n=31; 19.8%). A total of 183 DRP were identified (90 potential and 93 real) and 121 PI, of which 51.2% could be evaluated (n=62; 44 PI on effectiveness and 18 PI on safety). Conclusion: The PI carried out by community pharmacists were assessable and improved both the effectiveness and safety of medications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.